FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+6.24%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$212M
AUM Growth
+$212M
(+8.5%)
Cap. Flow
+$11.6M
Cap. Flow
% of AUM
5.47%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
65
New
3
Increased
31
Reduced
4
Closed
4
Top Buys
| 1 |
LHCG
LHC Group LLC
LHCG
|
$5.03M |
| 2 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$5.02M |
| 3 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$4.21M |
| 4 |
AtriCure
ATRC
|
$1.66M |
| 5 |
Esperion Therapeutics
ESPR
|
$1.63M |
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$4.27M |
| 2 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$3.97M |
| 3 |
LCI
Lannett Company, Inc.
LCI
|
$3.37M |
| 4 |
STAAR Surgical
STAA
|
$2.53M |
| 5 |
NeoGenomics
NEO
|
$1.21M |
Sector Composition
| 1 | Healthcare | 82.38% |
| 2 | Energy | 2.37% |
| 3 | Consumer Staples | 0.82% |
| 4 | Financials | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AtriCure
ATRC
$1.84B
| $19M | 8.96% | 772,861 +67,291 | +10% | +$1.66M |
|
|
2
NeoGenomics
NEO
$1.13B
| $14.8M | 6.97% | 2,737,943 -224,081 | -8% | -$1.21M |
|
|
AKRX
3
DELISTED
Akorn, Inc.
AKRX
| $12.2M | 5.76% | 280,098 +24,387 | +10% | +$1.06M |
|
|
SRGA
4
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $11.1M | 5.21% | 1,713,376 +150,712 | +10% | +$974K |
|
5
Harvard Bioscience
HBIO
$22M
| $9.74M | 4.58% | 1,708,022 +145,518 | +9% | +$829K |
|
|
AMAG
6
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $7.83M | 3.68% | 113,368 +72,673 | +179% | +$5.02M |
|
|
NXTM
7
DELISTED
NxStage Medical Inc.
NXTM
| $6.44M | 3.03% | 450,958 +39,241 | +10% | +$561K |
|
|
OXFD
8
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $6.21M | 2.92% | 448,365 +38,215 | +9% | +$529K |
|
|
ARRY
9
DELISTED
Array Biopharma Inc
ARRY
| $6.12M | 2.88% | 849,374 +73,648 | +9% | +$531K |
|
|
TEAR
10
DELISTED
TearLab Corporation
TEAR
| $6.1M | 2.87% | 3,017,872 +67,394 | +2% | +$136K |
|
|
SPNC
11
DELISTED
Spectranetics Corp
SPNC
| $5.73M | 2.7% | 249,187 +21,570 | +9% | +$496K |
|
12
Insmed
INSM
$28.8B
| $5.65M | 2.66% | 231,471 +21,405 | +10% | +$523K |
|
|
TLGT
13
DELISTED
Teligent, Inc
TLGT
| $5.55M | 2.61% | 880,961 +74,706 | +9% | +$471K |
|
14
Omnicell
OMCL
$1.5B
| $5.54M | 2.61% | 146,921 +13,063 | +10% | +$493K |
|
15
Veracyte
VCYT
$2.39B
| $5.37M | 2.53% | 482,263 +42,260 | +10% | +$471K |
|
|
LHCG
16
DELISTED
LHC Group LLC
LHCG
| $5.03M | 2.37% | +131,467 | New | +$5.03M |
|
|
17
Ligand Pharmaceuticals
LGND
$3.15B
| $4.96M | 2.33% | 49,115 -42,269 | -46% | -$4.27M |
|
18
Celldex Therapeutics
CLDX
$1.47B
| $4.67M | 2.2% | 185,333 +16,188 | +10% | +$408K |
|
|
ELGX
19
DELISTED
Endologix Inc
ELGX
| $4.67M | 2.2% | 304,602 +27,338 | +10% | +$419K |
|
20
Bio-Techne
TECH
$8.5B
| $4.62M | 2.17% | 46,921 +3,885 | +9% | +$383K |
|
|
ENZ
21
DELISTED
Enzo Biochem, Inc.
ENZ
| $4.36M | 2.05% | 1,439,330 +115,008 | +9% | +$348K |
|
|
CYNA
22
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $4.21M | 1.98% | +258,606 | New | +$4.21M |
|
23
QuidelOrtho
QDEL
$1.95B
| $3.96M | 1.87% | 172,668 +15,003 | +10% | +$344K |
|
24
AngioDynamics
ANGO
$417M
| $3.88M | 1.83% | 236,692 +20,909 | +10% | +$343K |
|
25
LeMaitre Vascular
LMAT
$2.16B
| $3.87M | 1.82% | 320,768 +28,649 | +10% | +$345K |
|